Congenica named in UK’s Digital Health Playbook - ‘First 100’ Companies
Congenica has been featured in the UK’s Digital Health Playbook ‘First 100’ as one of the UK’s most innovative and impactful digital health companies.
Congenica 3.1 - Automating best practices in variant interpretation
Congenica 3.1 release forms part of our ongoing commitment to embedding variant analysis best practices in an automated platform and intuitive workflow.
Congenica assures the clinical safety of NHS genomic analysis
Congenica clinical decision support and NGS data analysis provides a complete Clinical Risk Management Process in compliance with the DCB0129 standard
Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia
Camtech will market, distribute, sell Congenica rapid NGS data analysis software and clinical decision support in Singapore, Malaysia, Japan, South Korea
Making information about genomic medicine accessible to all
Article by: Alastair Kent OBE FRSA, Chair of the Congenica Patient Advocacy Advisory Board and former Executive Director of Genetic Alliance UK.
Congenica Appoints Jayesh Pankhania as Chief Financial Officer
Digital health company Congenica, providing rapid and accurate genomic data analysis software, appoints new Chief Financial Officer, Jayesh Pankhania.
Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing
Congenica announces a new contract with the Institute of Immunology and Genetics, a leading molecular genetic laboratory in Kaiserslautern, Germany
Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients
Sanford Health selects Congenica clinical decision support platform and NGS data analysis software to provide answers for undiagnosed rare disease patients
Congenica signs distribution agreement with AmpliTech in France
Congenica, the digital health company enabling rapid and accurate analysis of genomic data, announces a distribution agreement with AmpliTech.
Congenica Appoints Kamraan Shariff as Chief Business Development Officer
Congenica, the company enabling rapid and accurate NGS data analysis to transform lives, today announces the appointment of Kamraan Shariff.
Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants
Genomic sequencing has the potential to rapidly analyze critically ill babies and children and also to predict a response to infectious diseases and potential therapeutic compounds.